<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Psychiatry">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Psychiatry</JournalTitle>
      <Issn>1735-4587</Issn>
      <Volume>5</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2010</Year>
        <Month>03</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Efficacy and Safety of Oral Combination of Yohimbine and L-arginine (SX) for the Treatment of Erectile Dysfunction: a multicenter, randomized, double blind, placebo-controlled clinical trial</title>
    <FirstPage>1</FirstPage>
    <LastPage>3</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Shahin</FirstName>
        <LastName>Akhondzadeh</LastName>
        <affiliation locale="en_US">Psychiatry &amp; psychology Research Center, Roozbeh Hospital, Tehran University of Medical Center, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Afshar</FirstName>
        <LastName>Amiri</LastName>
        <affiliation locale="en_US">Psychiatry &amp; psychology Research Center, Roozbeh Hospital, Tehran University of Medical Center, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Amir Houshang</FirstName>
        <LastName>Bagheri</LastName>
        <affiliation locale="en_US">Psychiatry &amp; psychology Research Center, Roozbeh Hospital, Tehran University of Medical Center, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Objective: TThe objective of this study was to assess the efficacy and safety of SX (combination of yohimbine and L-arginine) in the treatment of erectile dysfunction (ED)
Methods: This trial was a 4-week, double blind study of parallel groups of patients with mild to moderate ED. Forty married male patients with ED of mild-to-moderate severity were screened for the study entry;among them, those aged 25-50 who reported a minimum of a- 3-month history of ED were eligible to enroll in this study. The severity of ED was based on EF domain scores on the international index of erectile function (IIEF). The scores of 15-25 was considered as mild to moderate ED. Patients were randomized to receive one capsule of SX or placebo on demand in a 1:1 ratio using a computer-generated code.The difference between the two groups was significant at week 4 (endpoint) (P=0.03). Four adverse events were observed over the study.
Results: The difference between the SX and placebo was not significant in the frequency of adverse events.
Conclusion: This study indicates that SX is safe and effective for the treatment of mild to moderate ED at least in the short-term.</abstract>
    <web_url>https://ijps.tums.ac.ir/index.php/ijps/article/view/384</web_url>
    <pdf_url>https://ijps.tums.ac.ir/index.php/ijps/article/download/384/380</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Psychiatry</JournalTitle>
      <Issn>1735-4587</Issn>
      <Volume>5</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2010</Year>
        <Month>03</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Effects of Herbal vigRX on Premature Ejaculation: A randomized, double-blind study</title>
    <FirstPage>4</FirstPage>
    <LastPage>6</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Firoozeh</FirstName>
        <LastName>Raisi</LastName>
        <affiliation locale="en_US">Psychiatry    and    Psychology  Research Center, Tehran University   of   Medical   Sciences,  Tehran, Iran &#xD;
Departmen    of    Psychiatry, Roozbeh Hospital, Tehran  University   of   Medical   Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Vahid</FirstName>
        <LastName>Farnia</LastName>
        <affiliation locale="en_US">Psychiatry    and    Psychology  Research Center, Tehran University   of   Medical   Sciences,  Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Nafiseh</FirstName>
        <LastName>Ghanbarian</LastName>
        <affiliation locale="en_US">Psychiatry    and    Psychology  Research Center, Tehran University   of   Medical   Sciences,  Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Z</FirstName>
        <LastName>Ghafuri</LastName>
        <affiliation locale="en_US">Departmen    of    Psychiatry, Roozbeh Hospital, Tehran  University   of   Medical   Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Objective: We conducted a double-blind, placebo-controlled study to determine the efficacy of an herbal sexual supplement (vigRX) on premature ejaculation (PE).
Method: A randomized double blind study was conducted on a fixed dose of herbal vigRX at Roozbeh Psychiatry Hospital, Tehran University of Medical Sciences. The sample consisted of 85 married patients diagnosed with primary PE according to Diagnostic and Statistical Manual of Mental Disorders. Each patient underwent diagnostic evaluation by one trained psychiatrist, using Structured Clinical Interview for DSM-IV-TR. Each patient was evaluated by researchers to exclude the organic sexual dysfunctions. The patients were randomly assigned in to two groups: group 1 consisting of 42 patients receiving placebo, and group 2 consisting of 43 patients receiving 540 mg herbal vigRX for a 4-week treatment course. The effects of the drug on the ejaculatory function in each group were assessed by the intravaginal ejaculation latency time (IELT), and the Chinese Index of Premature Ejaculation (CIPE) before and at the end of the treatment course. Statistical analysis was performed using SPSS software (15th version).The mean IELT increased 22.4 and 32.0 seconds in the placebo and the vigRX group respectively after the treatment course. The mean IELT differences between the two groups was not significant. The mean CIPE score increased 2.40 and 4.37 in the placebo and the vigRX group respectively.
Results: The mean CIPE score differences between the two groups was not significant.No side effect was reported by the subjects in neither groups during the treatment course.
Conclusion: Although the improvement in IELT and CIPE scores in the herbal vigRX group was more than the placebo group, this difference was not statistically significant. The increasing of IELT and CIPE score in the placebo group may be due to the placebo effects. Further studies with higher vigRX doses, greater sample size and longer treatment courses are warranted.</abstract>
    <web_url>https://ijps.tums.ac.ir/index.php/ijps/article/view/383</web_url>
    <pdf_url>https://ijps.tums.ac.ir/index.php/ijps/article/download/383/379</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Psychiatry</JournalTitle>
      <Issn>1735-4587</Issn>
      <Volume>5</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2010</Year>
        <Month>03</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Training Health Professionals to Conduct Family Education for Families of Patients with First-Episode Psychosis: Adherence to Protocol</title>
    <FirstPage>7</FirstPage>
    <LastPage>10</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Yasaman</FirstName>
        <LastName>Mottaghipour</LastName>
        <affiliation locale="en_US">Department of Psychiatry, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Niloofar</FirstName>
        <LastName>Salesian</LastName>
        <affiliation locale="en_US">Department  of  Psychiatry,  Psychiatry  and  Psychology  Research Center, Tehran  University of   Med ical  Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Arshia</FirstName>
        <LastName>Seddigh</LastName>
        <affiliation locale="en_US">Department    of    Psychiatry,  Psychiatry  and  Psychology  Research  Center,  Tehran  University   of   Med ical   Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohsen Jalali</FirstName>
        <LastName>Roudsari</LastName>
        <affiliation locale="en_US">Department    of    Psychiatry,  Psychiatry  and  Psychology  Research  Center,  Tehran  University   of   Med ical   Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Sahar Tahbaz</FirstName>
        <LastName>Hosseinzade</LastName>
        <affiliation locale="en_US">Department  of  Psychology, Tehran University, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Vandad</FirstName>
        <LastName>Sharifi</LastName>
        <affiliation locale="en_US">Department    of    Psychiatry,  Psychiatry  and  Psychology  Research  Center,  Tehran  University   of   Med ical   Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Objective: The&#xA0; implementation of&#xA0; family&#xA0; psychoeducation at&#xA0; the&#xA0; service delivery level is not without difficulty. Few mental health professionals receive special training to work with families especially in Iran.&#xA0;&#xA0; The aim of the present study was to evaluate the effectiveness of training health professionals in terms of their adherence to protocol.
 Method: Eight professionals (general practitioners, nurses and social workers) participated in a training program for health professionals as part of the Roozbeh First-Episode Psychosis Program&#xA0; (RooF) to&#xA0; conduct family psychoeducation. Training included a 3-day- workshop and 12 supervision sessions during the course of the implementation of the psychoeducation program. The family psychoeducation sessions (multiple-family group or single-family home-based) were tape-recorded. Transcripts of the audiotaped sessions were analyzed based on the content of the manual and were scored accordingly. 
Results: Twenty-four recorded sessions were analyzed in terms of th&#xA0; adherence&#xA0; to&#xA0; protocol,&#xA0; the&#xA0; number&#xA0; of&#xA0; questions&#xA0; and&#xA0; the&#xA0; time&#xA0; for&#xA0; each session.&#xA0; The&#xA0; overall&#xA0; rating&#xA0; showed&#xA0; a&#xA0; 72%&#xA0; adherence&#xA0; to&#xA0; the&#xA0; protocol. Multiple-family group sessions had a higher rate compared to the single- family home-based family psychoeducation sessions (79% to 69%) as well as the time spent and questions asked. The rate of adherence to the protocol of conducting the family psychoeducation sessions had not changed over time .
 Conclusion: Considering the amount of time taken for training and supervision, the level of adherence to the protocol was satisfactory. Tape recording sessions and&#xA0; regular&#xA0; supervision would be&#xA0; beneficial following specialized&#xA0; training.&#xA0; Further&#xA0; research&#xA0; is&#xA0; needed&#xA0; to&#xA0; tailor&#xA0; the&#xA0; amount&#xA0; of training and supervision required for professionals to conduct family psychoeducation programs in different settings.</abstract>
    <web_url>https://ijps.tums.ac.ir/index.php/ijps/article/view/382</web_url>
    <pdf_url>https://ijps.tums.ac.ir/index.php/ijps/article/download/382/378</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Psychiatry</JournalTitle>
      <Issn>1735-4587</Issn>
      <Volume>5</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2010</Year>
        <Month>03</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">The Effects of Histaminergic Agents in the Nucleus Accumbens of Rats in the Elevated Plus-Maze Test of Anxiety</title>
    <FirstPage>11</FirstPage>
    <LastPage>17</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Mohammad-Reza</FirstName>
        <LastName>Zarrindast</LastName>
        <affiliation locale="en_US">Department    of    Pharmacology, School    of    Medicine    and    Iranian   National Center for Addiction Studies,  Tehran      University      of      Medical  Sciences, Tehran, Iran &#xD;
Institute  for  Studies  in  Theoretical   Physics  and  Mathematics,  School  of   Cognitive Sciences, Tehran, Iran &#xD;
Institute   for   Cognitive   Science    Studies, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Saba</FirstName>
        <LastName>Taheri</LastName>
        <affiliation locale="en_US">Department   of   Biology,   Science and  Research  Branch,  Islamic  Azad University, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Ameneh</FirstName>
        <LastName>Rezayof</LastName>
        <affiliation locale="en_US">Department    of    Animal    Biology,  School     of     Biology,     College     of  Science,     University     of     Tehran,    Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Objective: The nucleus accumbens (NAc) receive histaminergic neurons from tuberomammillary nuclei. There are reports indicating that central histamine systems are involved in many physiological behavioral processes, including anxiety. The aim of the present study was to assess whether the histaminergic system of the NAc is involved in anxiety-related behaviors.
Methods:&#xA0;&#xA0; Rats&#xA0;&#xA0; were&#xA0;&#xA0; anesthetized&#xA0;&#xA0; with&#xA0;&#xA0; intra-peritoneal&#xA0;&#xA0; injection&#xA0;&#xA0; of
ketamine&#xA0; hydrochloride,&#xA0; plus&#xA0; xylazine&#xA0; and&#xA0; then&#xA0;&#xA0; were&#xA0; placed&#xA0; in&#xA0; a stereotaxic&#xA0; apparatus.&#xA0; In&#xA0; addition,&#xA0; two&#xA0; stainless-steel&#xA0; cannuale&#xA0; were placed 2 mm above the nucleus accumbens shell. Seven days after recovery from surgery, the behavioral testing was started.&#xA0; As a model of anxiety, the elevated plus maze which is a useful test to investigate the effects of anxiogenic or anxiolytic drugs in rodents, was used in male Wistar rats.
Results: Intra-NAc administration of histamine (0.01, 0.1 and 1 &#xB5;g/rat) increased the percentage of open arm time (%OAT) and open arm entries (%OAE)&#xA0; ,but&#xA0; not&#xA0; locomotor&#xA0; activity,&#xA0; indicating&#xA0; an&#xA0; anxiolytic&#xA0; response.
Furthermore, bilateral microinjections of different doses of the H1 receptor antagonist pyrilamine (0.001, 0.01, 0.1 and 1 &#xB5;g/rat) or the H2&#xA0; receptor antagonist ranitidine (0.001, 0.01, 0.1 and 1 &#xB5;g/rat) into the NAc increased
%OAT and %OAE , but not locomotor activity. However, both histamine and histamine receptor antagonists showed an anxiolytic-like effect ; the antagonists (1 &#xB5;g/rat) also decreased the histamine response.
Conclusion: The results may indicate a modulatory effect for the H1&#xA0; and H2&#xA0; histamine receptors of nucleus accumbens in the anxiety behavior of rats.</abstract>
    <web_url>https://ijps.tums.ac.ir/index.php/ijps/article/view/381</web_url>
    <pdf_url>https://ijps.tums.ac.ir/index.php/ijps/article/download/381/377</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Psychiatry</JournalTitle>
      <Issn>1735-4587</Issn>
      <Volume>5</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2010</Year>
        <Month>03</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Effect of Early Intervention with Omega-3 on Insulin Resistance in Patients Initiated on Olanzapine with either Sodium Valproate or Lithium: A randomized, Double-blind, Placebo-Controlled Trial</title>
    <FirstPage>18</FirstPage>
    <LastPage>22</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Toktam</FirstName>
        <LastName>Faghihi</LastName>
        <affiliation locale="en_US">Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Padideh</FirstName>
        <LastName>Ghaeli</LastName>
        <affiliation locale="en_US">Department      of      Clinical  Pharmacy,  Faculty  of  Pharmacy, Tehran    University    of    Medical  Sciences, Tehran, Iran Psychiatry    and    Psychology Research       Center,       Roozbeh  Psychiatric      Hospital,      Tehran    University   of   Medical   Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Adel</FirstName>
        <LastName>Jahed</LastName>
        <affiliation locale="en_US">Department  of  Endocrinology   and   Internal   Medicine,   Boo-ali   University  Hospital,  Islamic  Azad   University,       Tehran       Medical   Branch, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Javad</FirstName>
        <LastName>Mahmoudi-Gharaei</LastName>
        <affiliation locale="en_US">Psychiatry    and    Psychology Research       Center,       Roozbeh  Psychiatric      Hospital,      Tehran    University   of   Medical   Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Vandad</FirstName>
        <LastName>Sharifi</LastName>
        <affiliation locale="en_US">Department    of    Psychiatry,   Roozbeh     Psychiatric     Hospital,    Tehran    University    of    Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Akhondzadeh</FirstName>
        <LastName>Shahin</LastName>
        <affiliation locale="en_US">Psychiatry    and    Psychology Research       Center,       Roozbeh  Psychiatric      Hospital,      Tehran    University   of   Medical   Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Objective: Metabolic side effects of the second generation (atypical) antipsychotics have been a forefront of attention since their availability. One common&#xA0; &#xA0;concern&#xA0;&#xA0; is&#xA0;&#xA0; the&#xA0;&#xA0; development&#xA0; &#xA0;of&#xA0;&#xA0; hyperglycemia&#xA0;&#xA0; and&#xA0;&#xA0; insulin resistance. The aim of this study was to evaluate the effect of early initiation of omega-3 fatty acids supplementation on glucose-insulin homeostasis in a group of psychiatric patients under treatment with olanzapine and sodium valproate or lithium combination.
Method: In a double-blind design, eligible participants with schizophrenia, bipolar I, and schizoaffective disorders who were initiated on olanzapine combination &#xA0;with &#xA0;sodium &#xA0;valproate &#xA0;or &#xA0;lithium were randomly assigned to receive omega-3 or identical placebo capsules for 6 weeks. Fasting blood sugar (FBS), insulin and HbA1c &#xA0;were measured at the baseline and at the end of the 6th&#xA0; week. Homeostatic model assessment of insulin resistance (HOMA-IR), as a measure of insulin resistance, was also determined at the same times.
Results: At the end of the study, no significant difference was observed between the two arms in terms of FBS, fasting insulin, HbA1c and HOMA-IR. However, trends toward decreasing both fasting insulin levels (p= 0.06) and HOMA-IR &#xA0;(p= &#xA0;0.07) &#xA0;were &#xA0;noted &#xA0;in &#xA0;the&#xA0; group&#xA0; receiving&#xA0; omega-3.&#xA0; No significant &#xA0;changes &#xA0;in &#xA0;the &#xA0;outcome &#xA0;variables &#xA0;were &#xA0;observed&#xA0; from&#xA0; the baseline to the final measurements in both groups.
Conclusion: This study noted that adding omega-3 fatty acids at the commencement of olanzapine combination therapy with valproate or lithium could not favorably influence glucose-insulin homeostasis. However, trends toward a decrease in insulin levels (p= 0.06) and HOMA-IR (p= 0.07) observed in patients receiving omega-3 suggest a possible beneficial role of this supplement in this population and, therefore, warrant further evaluation.</abstract>
    <web_url>https://ijps.tums.ac.ir/index.php/ijps/article/view/380</web_url>
    <pdf_url>https://ijps.tums.ac.ir/index.php/ijps/article/download/380/376</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Psychiatry</JournalTitle>
      <Issn>1735-4587</Issn>
      <Volume>5</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2010</Year>
        <Month>03</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Association of Premorbid Adjustment with Symptom Profile and Quality of Life in First Episode Psychosis in a Tertiary Hospital in Tehran, Iran</title>
    <FirstPage>23</FirstPage>
    <LastPage>27</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Javad</FirstName>
        <LastName>Mahmoodi-Gharaei</LastName>
        <affiliation locale="en_US">Psychiatry and Psychology Research Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Anahita</FirstName>
        <LastName>Basirnia</LastName>
        <affiliation locale="en_US">Roozbeh  Hospital,  Psychiatry Department,  Tehran  University  of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Neda</FirstName>
        <LastName>Abedi</LastName>
        <affiliation locale="en_US">Roozbeh  Hospital,  Psychiatry Department,  Tehran  University  of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Behrang</FirstName>
        <LastName>Shadloo</LastName>
        <affiliation locale="en_US">Roozbeh  Hospital,  Psychiatry Department,  Tehran  University  of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Sara</FirstName>
        <LastName>Jafari</LastName>
        <affiliation locale="en_US">Roozbeh  Hospital,  Psychiatry Department,  Tehran  University  of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Niloofar</FirstName>
        <LastName>Salesian</LastName>
        <affiliation locale="en_US">Roozbeh  Hospital,  Psychiatry Department,  Tehran  University  of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohsen</FirstName>
        <LastName>Djalali</LastName>
        <affiliation locale="en_US">Roozbeh  Hospital,  Psychiatry Department,  Tehran  University  of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Vandad</FirstName>
        <LastName>Sharifi</LastName>
        <affiliation locale="en_US">Roozbeh  Hospital,  Psychiatry Department,  Tehran  University  of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Objective: Poor premorbid adjustment has been reported to be a predictor of more severe psychotic symptoms and poor quality of life in such psychotic disorders &#xA0;as &#xA0;schizophrenia. &#xA0;However, &#xA0;most &#xA0;studies &#xA0;were&#xA0; performed&#xA0; on chronic schizophrenic patients, and proposed the likelihood of recall biases and the effect of chronicity. &#xA0;The aim of this study was to investigate 02</Month>
        <Day>06</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Objective: The Social Responsiveness Scale-2 (SRS-2) is a well-known screening instrument to assess autistic spectrum symptoms quantitatively. This study assessed the different types of reliability of the Farsi translation of the scale.
Method: This scale was translated into Farsi and back translated considering all aspects of methodology in translation. Then, based on stratified sampling, 533 7-11-year-old students were randomly selected from the mainstream schools located in the central parts of Tehran, the capital of Iran. For all the students, SRS-2 was completed by both the parents and teachers. To check retest reliability, the test was administered again for 15% of the total participants after a 2-4 week-period. Cronbach&#x2019;s alpha coefficient, split-half&#x201D; and Gottman&#x201D; methods, and intra-class correlation coefficient (ICC) were used.
Results: The mean total raw score was 48.47 (&#xB1;23.63) and 53.17 (&#xB1;27.33) in the sequence of the parents and teachers&#x2019; reports. The internal consistency (Cronbach&#x2019;s alpha; 0.86 and 0.89), test-retest reliability (ICC; 0.72 and 0.83 for parents and teacher&#x2019; ratings, respectively), and interrater reliability (ICC; 0.72) showed well-accepted measurement performance.
Conclusion: The findings indicated that the Farsi SRS-2 can be used as a reliable instrument to measure social responsiveness as autistic symptoms in Iranian child population.</abstract>
    <web_url>https://ijps.tums.ac.ir/index.php/ijps/article/view/1669</web_url>
    <pdf_url>https://ijps.tums.ac.ir/index.php/ijps/article/download/1669/901</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Psychiatry</JournalTitle>
      <Issn>1735-4587</Issn>
      <Volume>15</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2020</Year>
        <Month>02</Month>
        <Day>10</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Stress and Anxiety Levels Are Associated with Erythrocyte Fatty Acids Content in Young Women</title>
    <FirstPage>47</FirstPage>
    <LastPage>54</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Samira</FirstName>
        <LastName>Hashemi</LastName>
        <affiliation locale="en_US">Health Research Institute, Diabetes Research Centre, Department of Nutrition, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Reza</FirstName>
        <LastName>Amani</LastName>
        <affiliation locale="en_US">Department of Clinical Nutrition, School of Nutrition and Food Science, Food Security Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Bahman</FirstName>
        <LastName>Cheraghian</LastName>
        <affiliation locale="en_US">Department of Biostatistics and Epidemiology, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Sorour</FirstName>
        <LastName>Neamatpour</LastName>
        <affiliation locale="en_US">Department of Psychiatry, Golestan Medical Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2017</Year>
        <Month>08</Month>
        <Day>12</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Objective: Recent studies have revealed that fatty acid profile can be associated with psychological disorders. However, evidence on stress and anxiety is scarce. The aim of this study was to investigate the relationship between stress and anxiety, defined as mood states, and erythrocyte fatty acid (FA) profile.
Method: This case-control study was conducted on 45 female students with degrees of stress and anxiety without depression disorder and 45 matched controls with no depression, stress, or anxiety. Self-administered questionnaires included a 28-item Food Frequency questionnaire and Depression Anxiety Stress Scales (DASS-21), which were used to measure dietary patterns and psychological disorders, respectively. Erythrocyte membrane fatty acids were analyzed using gas-liquid chromatography.
Results: Docosahexaenoic acid (DHA) was significantly lower in the case group (p = 0.008). Hydrogenated fats were associated with degrees of stress and anxiety (OR = 1.53, p = 0.019), while linoleate and DHA were inversely associated with stress and anxiety scores (OR = 0.37, p = 0.05; OR = 0.31, p = 0.014, respectively). Monounsaturated FAs (MUFAs) and total RBC trans FA were associated with increased risk of stress and anxiety (OR = 1.81, p &lt; 0.001; OR = 3.38, p = 0.003, respectively).
Conclusion: Trans-fatty acids may be related to stress and anxiety scales but linoleate and DHA could decrease the risk. The effect of MUFAs may be regarded as a result of compensatory biological mechanisms.</abstract>
    <web_url>https://ijps.tums.ac.ir/index.php/ijps/article/view/1169</web_url>
    <pdf_url>https://ijps.tums.ac.ir/index.php/ijps/article/download/1169/902</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Psychiatry</JournalTitle>
      <Issn>1735-4587</Issn>
      <Volume>15</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2020</Year>
        <Month>02</Month>
        <Day>10</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Association of Internet Addiction with Emotional and Behavioral Characteristics of Adolescents</title>
    <FirstPage>55</FirstPage>
    <LastPage>66</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Mohammad</FirstName>
        <LastName>Effatpanah</LastName>
        <affiliation locale="en_US">School of Medicine, Ziaeian Hospital, International Campus, Tehran University of Medical Science, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad</FirstName>
        <LastName>Moharrami</LastName>
        <affiliation locale="en_US">School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Gilda</FirstName>
        <LastName>Rajabi Damavandi</LastName>
        <affiliation locale="en_US">Ziaeian Hospital, Tehran University of Medical Science, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mahdi</FirstName>
        <LastName>Aminikhah</LastName>
        <affiliation locale="en_US">Department of Epidemiology and Biostatistics, School of Public health, Tehran University of Medical Science, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad</FirstName>
        <LastName>Hosein Nezhad</LastName>
        <affiliation locale="en_US">Farhangiyan University, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Farnaz</FirstName>
        <LastName>Khatami</LastName>
        <affiliation locale="en_US">Family Medicine Department, Ziaeian Hospital, Tehran University of Medical Science, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Tara</FirstName>
        <LastName>Arjmand</LastName>
        <affiliation locale="en_US">Ziaeian Hospital, Tehran University of Medical Science, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Heliya</FirstName>
        <LastName>Tarighatnia</LastName>
        <affiliation locale="en_US">Ziaeian Hospital, Tehran University of Medical Science, Tehran, Iran.</affiliation>
      </Author>
      <